Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia

4 June 2008

journal article
research article
Published by Springer Science and Business Media LLC in Intensive Care Medicine

Vol. 34 (11), 2084-2091
https://doi.org/10.1007/s00134-008-1173-x

Abstract

This study aimed to investigate the correlation of midregional pro-atrial natriuretic peptide (MR-proANP) with severity of septic status in patients with ventilator-associated pneumonia (VAP) and the usefulness of MR-proANP for mortality prediction in VAP.

Keywords

This publication has 30 references indexed in Scilit:

Midregional Pro-A-Type Natriuretic Peptide and Carboxy-Terminal Provasopressin May Predict Prognosis in Community-Acquired Pneumonia
Clinical Chemistry, 2007
Atrial natriuretic peptide in children with pneumonia
Pediatric Pulmonology, 2005
Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human Plasma
Clinical Chemistry, 2004
Atrial Natriuretic Peptide Prohormone Gene Expression: Hormones and Diseases That Upregulate its Expression
IUBMB Life, 2002
α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock
Critical Care Medicine, 2001
Biochemical detection of left-ventricular systolic dysfunction
The Lancet, 1998
Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat
Critical Care Medicine, 1995
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
Chest, 1992
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
Critical Care Medicine, 1992
APACHE II
Critical Care Medicine, 1985

Cited by 36 articles